Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Small

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
The American Journal of Psychiatry|December 1, 1995
Predictors of cognitive change in middle-aged and older adults with memory lossG W Small, A La Rue, S Komo, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|August 10, 1999
Crystal structure of bullfrog M ferritin at 2.8 A resolution: analysis of subunit interactions and the binuclear metal centerY Ha, D Shi, G W Small, et al.
International Psychogeriatrics|March 1, 1997
Mnemonics usage and cognitive decline in age-associated memory impairmentG W Small, A La Rue, S Komo, et al.
Journal of the American Geriatrics Society|August 1, 1985
Thyroid disease in patients with dementia of the Alzheimer typeG W Small, S S Matsuyama, R Komanduri, et al.
Current Medical Research and Opinion|November 13, 2004
Effects of galantamine in patients with mild Alzheimer's diseaseJ-M Orgogozo, G W Small, G Hammond, et al.
Journal of Geriatric Psychiatry and Neurology|April 1, 1989
HLA antigens in depressed, demented, and nondemented elderlyG W Small, S S Matsuyama, R Komanduri, et al.
European Journal of Neurology|December 3, 2003
Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular diseaseA F Kurz, T Erkinjuntti, G W Small, et al.
International Psychogeriatrics|January 1, 1995
Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study GroupG W Small, S H Hamilton, A Bystritsky, et al.
Biological Psychiatry|March 11, 1999
Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's diseaseM L Levy, J L Cummings, L A Fairbanks, et al.
Journal of the American Geriatrics Society|October 1, 1996
Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study GroupG W Small, M Birkett, B S Meyers, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
The American Journal of Psychiatry|December 1, 1995
Predictors of cognitive change in middle-aged and older adults with memory lossG W Small, A La Rue, S Komo, et al.
Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|August 10, 1999
Crystal structure of bullfrog M ferritin at 2.8 A resolution: analysis of subunit interactions and the binuclear metal centerY Ha, D Shi, G W Small, et al.
International Psychogeriatrics|March 1, 1997
Mnemonics usage and cognitive decline in age-associated memory impairmentG W Small, A La Rue, S Komo, et al.
Journal of the American Geriatrics Society|August 1, 1985
Thyroid disease in patients with dementia of the Alzheimer typeG W Small, S S Matsuyama, R Komanduri, et al.
Current Medical Research and Opinion|November 13, 2004
Effects of galantamine in patients with mild Alzheimer's diseaseJ-M Orgogozo, G W Small, G Hammond, et al.
Journal of Geriatric Psychiatry and Neurology|April 1, 1989
HLA antigens in depressed, demented, and nondemented elderlyG W Small, S S Matsuyama, R Komanduri, et al.
European Journal of Neurology|December 3, 2003
Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer's disease with cerebrovascular diseaseA F Kurz, T Erkinjuntti, G W Small, et al.
International Psychogeriatrics|January 1, 1995
Clinical response predictors in a double-blind, placebo-controlled trial of fluoxetine for geriatric major depression. Fluoxetine Collaborative Study GroupG W Small, S H Hamilton, A Bystritsky, et al.
Biological Psychiatry|March 11, 1999
Apolipoprotein E genotype and noncognitive symptoms in Alzheimer's diseaseM L Levy, J L Cummings, L A Fairbanks, et al.
Journal of the American Geriatrics Society|October 1, 1996
Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study GroupG W Small, M Birkett, B S Meyers, et al.
Pageof 16